FON-2021-1367.docx (19.65 kB)
fon-2021-1367 – First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population
Version 2 2022-05-19, 08:05
Version 1 2022-05-17, 11:00
dataset
posted on 2022-05-17, 11:00 authored by Figshare Future Science GroupFigshare Future Science Group, Alycia Hatashima, Matthew J Arango, Joshua Reardon, Tracelyn Freeman, Terence Williams, Eric M McLaughlin, Laith Abushahin
Table S1 Hazard Ratios with and without Inverse Probability Weights
Table S2 Multivariate Analysis: Prognostic Factors for Overall Survival
